Vendor status logFDA letter
Swiss Chems (Swisschems): status log
Site responding; FDA warning letter Dec 10 2024
Domains: swisschems.is · Last checked 2026-10-19 · Reviewed by Amino Wire Editorial Team
Summary
FDA sent Swisschems a warning letter dated December 10, 2024, saying its semaglutide and retatrutide products were unapproved new drugs despite “research chemicals only” labeling. On October 19, 2026, swisschems.is returned a storefront page.
Dated facts
1 entries · newest first-
FDA warning letter
FDA (CDER) warning letter 695663: website reviewed October 2024; “Semaglutide” and “Retatrutide” products found to be unapproved new drugs; social posts cited as evidence of intended use.
Our site checks
automated · single location| Checked (UTC) | URL | HTTP | What loaded |
|---|---|---|---|
| 2026-10-19 06:18:00 | https://swisschems.is/ | 200 | HTTP 200; title “SwissChems - Home”. The response included add-to-cart markup, which suggests a storefront was being served. We did not place an order and cannot say whether orders ship. |
A page loading does not show that a business is lawful, that orders are fulfilled, or anything about product quality. We did not place orders.
Notes and unknowns
- FDA's website does not show whether or how the company responded. A posted warning letter is an advisory notice, not a court finding.